Detailed information for compound 328937

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 299.278 | Formula: C16H13NO5
  • H donors: 2 H acceptors: 4 LogP: 2.93 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCOC(=O)c1cc(O)cc2c1oc(n2)c1ccc(cc1)O
  • InChi: 1S/C16H13NO5/c1-2-21-16(20)12-7-11(19)8-13-14(12)22-15(17-13)9-3-5-10(18)6-4-9/h3-8,18-19H,2H2,1H3
  • InChiKey: UEWDFYUQUGCZHV-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens estrogen receptor 2 (ER beta) Starlite/ChEMBL References
Homo sapiens estrogen receptor 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Loa Loa (eye worm) hypothetical protein estrogen receptor 2 (ER beta) 495 aa 418 aa 25.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Loa Loa (eye worm) hypothetical protein 0.0338 0.1332 0.1332
Plasmodium falciparum phosphatidylinositol 3- and 4-kinase, putative 0.0115 0 0.5
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.1786 1 1
Trypanosoma cruzi phosphatidylinositol kinase related protein, putative 0.0338 0.1332 0.1332
Trichomonas vaginalis PIKK family atypical protein kinase 0.0599 0.2895 0.2895
Plasmodium vivax phosphatidylinositol 4-kinase, putative 0.0115 0 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0223 0.0642 0.0642
Trypanosoma brucei target of rapamycin kinase 3, putative 0.1422 0.7822 0.7822
Trichomonas vaginalis PIKK family atypical protein kinase 0.1786 1 1
Loa Loa (eye worm) hypothetical protein 0.0376 0.1563 0.1563
Trichomonas vaginalis PIKK family atypical protein kinase 0.1786 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7261 0.7261
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7261 0.7261
Trichomonas vaginalis PIKK family atypical protein kinase 0.1067 0.5698 0.5698
Trichomonas vaginalis PIKK family atypical protein kinase 0.0479 0.2178 0.2178
Trichomonas vaginalis PIKK family atypical protein kinase 0.1056 0.5634 0.5634
Trichomonas vaginalis PIKK family atypical protein kinase 0.0963 0.5074 0.5074
Echinococcus granulosus phosphatidylinositol 3 and 4 kinase 0.0599 0.2895 0.2895
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.1786 1 1
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0599 0.2895 0.2895
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7261 0.7261
Entamoeba histolytica Phosphatidylinositol 3- and 4-kinase family 0.0338 0.1332 0.1332
Loa Loa (eye worm) hypothetical protein 0.0364 0.1489 0.1489
Plasmodium falciparum phosphatidylinositol 3-kinase 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.1159 0.625 0.625
Loa Loa (eye worm) hypothetical protein 0.0223 0.0642 0.0642
Trichomonas vaginalis PIKK family atypical protein kinase 0.0964 0.5082 0.5082
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7261 0.7261
Mycobacterium tuberculosis Conserved hypothetical protein 0.0115 0 0.5
Schistosoma mansoni ataxia telangiectasia mutated (atm)-related 0.1786 1 1
Trypanosoma brucei phosphatidylinositol kinase related protein, putative 0.0338 0.1332 0.1332
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7261 0.7261
Trypanosoma cruzi phosphatidylinositol 3-kinase, putative 0.0338 0.1332 0.1332
Trichomonas vaginalis PIKK family atypical protein kinase 0.1198 0.6481 0.6481
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7261 0.7261
Entamoeba histolytica hypothetical protein 0.0338 0.1332 0.1332
Echinococcus multilocularis PIK kinase, FAT and Armadillo domain containing protein 0.0261 0.0873 0.0873
Trichomonas vaginalis PIKK family atypical protein kinase 0.0964 0.5082 0.5082
Trichomonas vaginalis PIKK family atypical protein kinase 0.142 0.7813 0.7813
Trypanosoma cruzi target of rapamycin kinase 3 0.1422 0.7822 0.7822
Trichomonas vaginalis conserved hypothetical protein 0.0261 0.0873 0.0873
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0599 0.2895 0.2895
Trichomonas vaginalis PIKK family atypical protein kinase 0.0338 0.1332 0.1332
Trichomonas vaginalis PIKK family atypical protein kinase 0.1525 0.8437 0.8437
Plasmodium vivax phosphatidylinositol 3-kinase, putative 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0338 0.1332 0.1332
Echinococcus granulosus FKBP12 rapamycin complex associated protein 0.1786 1 1
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor1 0.1786 1 1
Trichomonas vaginalis conserved hypothetical protein 0.0376 0.1563 0.1563
Loa Loa (eye worm) hypothetical protein 0.0261 0.0873 0.0873
Trypanosoma cruzi phosphatidylinositol 3-related kinase, putative 0.0599 0.2895 0.2895
Echinococcus multilocularis FKBP12 rapamycin complex associated protein 0.1786 1 1
Onchocerca volvulus 0.0115 0 0.5
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.1786 1 1
Trypanosoma brucei phosphatidylinositol 3-kinase tor, putative 0.0845 0.4366 0.4366
Trichomonas vaginalis PIKK family atypical protein kinase 0.142 0.7813 0.7813
Schistosoma mansoni fkbp-rapamycin associated protein 0.0338 0.1332 0.1332
Trichomonas vaginalis PIKK family atypical protein kinase 0.0963 0.5074 0.5074
Leishmania major phosphatidylinositol 3-related kinase, putative 0.0599 0.2895 0.2895
Echinococcus granulosus serine:threonine protein kinase SMG1 0.0338 0.1332 0.1332
Onchocerca volvulus 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0599 0.2895 0.2895
Trichomonas vaginalis PIKK family atypical protein kinase 0.1056 0.5634 0.5634
Mycobacterium leprae conserved hypothetical protein 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.142 0.7813 0.7813
Trichomonas vaginalis PIKK family atypical protein kinase 0.0964 0.5082 0.5082
Leishmania major target of rapamycin kinase (TOR) kinase 3 0.1422 0.7822 0.7822
Plasmodium vivax phosphatidylinositol 4-kinase, putative 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.1067 0.5698 0.5698
Trichomonas vaginalis PIKK family atypical protein kinase 0.0963 0.5074 0.5074
Schistosoma mansoni hypothetical protein 0.0261 0.0873 0.0873
Leishmania major target of rapamycin (TOR) kinase 2, putative 0.1786 1 1
Trypanosoma cruzi phosphatidylinositol kinase related protein, putative 0.0223 0.0642 0.0642
Plasmodium vivax hypothetical protein, conserved 0.0115 0 0.5
Echinococcus multilocularis serine:threonine protein kinase SMG1 0.0338 0.1332 0.1332
Plasmodium vivax hypothetical protein 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.142 0.7813 0.7813
Schistosoma mansoni ataxia telangiectasia mutated (atm) 0.0338 0.1332 0.1332
Toxoplasma gondii FATC domain-containing protein 0.0338 0.1332 0.1835
Plasmodium falciparum phosphatidylinositol 4-kinase 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.1786 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.1328 0.7261 0.7261
Echinococcus granulosus serine protein kinase ATM 0.0338 0.1332 0.1332
Entamoeba histolytica protein kinase rad3, putative 0.0338 0.1332 0.1332
Toxoplasma gondii target of rapamycin (TOR), putative 0.1328 0.7261 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0964 0.5082 0.5082
Plasmodium vivax phosphatidylinositol 3- and 4-kinase, putative 0.0115 0 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.0599 0.2895 0.2895
Giardia lamblia GTOR 0.1786 1 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.0599 0.2895 0.2895
Echinococcus multilocularis serine protein kinase ATM 0.0338 0.1332 0.1332
Schistosoma mansoni phosphatidylinositol 3-and 4-kinase 0.0599 0.2895 0.2895
Trypanosoma cruzi Phosphatidylinositol 3-kinase tor2 0.1786 1 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0338 0.1332 0.1332
Trichomonas vaginalis PIKK family atypical protein kinase 0.142 0.7813 0.7813
Trichomonas vaginalis PIKK family atypical protein kinase 0.0223 0.0642 0.0642
Echinococcus granulosus PIK kinase FAT and Armadillo domain containing protein 0.0261 0.0873 0.0873
Leishmania major phosphatidylinositol 3-kinase, putative 0.0599 0.2895 0.2895
Trichomonas vaginalis PIKK family atypical protein kinase 0.0599 0.2895 0.2895
Brugia malayi FAT domain containing protein 0.0261 0.0873 0.0873
Echinococcus multilocularis phosphatidylinositol 3 and 4 kinase 0.0599 0.2895 0.2895
Trichomonas vaginalis PIKK family atypical protein kinase 0.0338 0.1332 0.1332
Leishmania major target of rapamycin (TOR) kinase 1, putative 0.1786 1 1
Toxoplasma gondii non-specific serine/threonine protein kinase 0.0376 0.1563 0.2153
Trypanosoma brucei FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative 0.0742 0.375 0.375
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0338 0.1332 0.1332
Loa Loa (eye worm) phosphatidylinositol 3 0.1786 1 1
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.1786 1 1
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0599 0.2895 0.2895
Loa Loa (eye worm) phosphatidylinositol 3 0.0599 0.2895 0.2895
Trichomonas vaginalis PIKK family atypical protein kinase 0.1067 0.5698 0.5698
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.0599 0.2895 0.2895

Activities

Activity type Activity value Assay description Source Reference
Activity (binding) = 83 % Regulation of IGFBP-4 MRNA in SAOS-2 cells expressing human beta Estrogen receptor in terms of percent activity, relative to 10 nM 17-beta-estradiol ChEMBL. 15456246
Activity (binding) = 83 % Regulation of IGFBP-4 MRNA in SAOS-2 cells expressing human beta Estrogen receptor in terms of percent activity, relative to 10 nM 17-beta-estradiol ChEMBL. 15456246
IC50 (binding) = 190 nM Inhibitory concentration against human ER beta expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand ChEMBL. 15456246
IC50 (binding) = 190 nM Inhibitory concentration against human ER beta expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand ChEMBL. 15456246
IC50 (binding) = 190 nM Binding affinity to ERbeta ChEMBL. 17459530
IC50 (binding) = 7827 nM Inhibitory concentration against human ER alpha expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand ChEMBL. 15456246
IC50 (binding) = 7827 nM Inhibitory concentration against human ER alpha expressed in E. coli was determined using [3H]-17-beta-estradiol as radio ligand ChEMBL. 15456246
Selectivity (binding) = 41 Selectivity fold for estrogen receptor beta over estrogen receptor alpha ChEMBL. 15456246
Selectivity (binding) = 41 Selectivity fold for estrogen receptor beta over estrogen receptor alpha ChEMBL. 15456246

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.